Is JNJ a good investment in 2026?

Johnson & Johnson trades at a P/E ratio of 27.1, with medium volatility (19.6% annualized). The stock is in a consolidation phase.

What is the risk level of JNJ?

Based on 30-day volatility of 19.6%, JNJ has MEDIUM risk. Beta of 0.26 indicates lower sensitivity to market movements than average.

Johnson & Johnson (JNJ) Stock Analysis & Price Outlook

Q: Does JNJ pay dividends?

Johnson & Johnson currently does not pay a regular dividend.

Key Metrics

MARKET CAP

$563.77B

P/E RATIO

27.1

BETA

0.26

Less volatile

DIV YIELD

N/A

52W HIGH

$251.71

52W LOW

$149.04

VOLATILITY

19.6%

30d annualized

Price Performance

30-DAY PRICE CHART

$228.92 → $234.20+2.31%

30 days agoToday

1-YEAR PERFORMANCE

$149.79 → $234.20+56.4%

JNJ | 52-week chartLast updated: 6/17/2026

Healthcare Sector Context

Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.

METRIC	JNJ	SECTOR AVG	VS SECTOR
P/E Ratio	27.1x	22.0x	↑ 23%
Beta	0.26	0.85	Less volatile
30d Volatility	19.6%	22%	Lower risk

TOP HEALTHCARE PEERS

UNH PFPFE ABABBV

Competitors Analysis

Compare JNJ's key metrics against its main healthcare sector competitors.

COMPANY	PRICE	MARKET CAP	SECTOR
JNJ(You are here)	$234.20	$563.77B	Healthcare	—
UNH	$399.53	$362.83B	Healthcare	VIEW →
PFPFE	$25.92	$147.73B	Healthcare	VIEW →
ABABBV	$221.23	$390.87B	Healthcare	VIEW →

Click on a competitor to view their full analysis

Technical Analysis

Johnson & Johnson is currently trading at $234.20, which is 7.0% below its 52-week high. With a beta of 0.26, the stock shows lower sensitivity to market movements.

RSI (14)NEUTRAL

30-DAY TRENDNEUTRAL

VOLUME8.4M(Above avg)

Frequently Asked Questions

Is JNJ a good buy right now?

Johnson & Johnson trades at 27.1x earnings. This is near market average. Current risk level is Medium based on 19.6% volatility.

Does JNJ pay dividends?

Johnson & Johnson does not currently pay a regular dividend. The company may be reinvesting profits for growth.

How volatile is JNJ?

With 30-day annualized volatility of 19.6% and beta of 0.26,JNJ is classified as Medium risk. The stock tends to be more stable than the market average.

Related Assets

LLLLYANALYZE →

Eli Lilly and Company

Track JNJ Live

Add Johnson & Johnson to your Portfolio Terminal for real-time alerts and risk updates.

OPEN TERMINAL IMPORT BROKER FILE

Last updated: 6/17/2026, 10:01:19 PM